Preliminary results from fight-102: a phase 1 study of pemigatinib in Japanese patients with advanced malignancies

被引:1
作者
Kuboki, Yasutoshi [1 ]
Furukawa, Masayuki [2 ]
Takahashi, Yasuo [3 ]
Mizuno, Nobumasa [4 ]
Hara, Hiroki [5 ]
Ueno, Makoto [6 ]
Ioka, Tatsuya [7 ]
Takahashi, Shunji [8 ]
Shimizu, Toshio [9 ]
Lihou, Christine F. [10 ]
Tian, Chenwei [10 ]
Ji, Tao [10 ]
Fujiwara, Yutaka [9 ]
机构
[1] Natl Canc Cent Hosp East, Kashiwa, Chiba, Japan
[2] Kyushu Canc Ctr, Minami Ku, Fukuoka, Fukuoka, Japan
[3] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[5] Saitama Canc Ctr, Saitama, Japan
[6] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[7] Osaka Int Canc Inst, Osaka, Japan
[8] JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan
[9] Natl Canc Ctr, Chuo Ku, Tokyo, Japan
[10] Incyte Corp, Wilmington, DE USA
关键词
D O I
10.1093/annonc/mdz343.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1 - 156
引用
收藏
页数:1
相关论文
empty
未找到相关数据